Recently, Injective (INJ) has been consolidating, creating conditions for a potential breakout. Technical indicators confirm an important move may be coming in the next weeks.
Technical Structure and Predictions
A recent analysis shows that INJ is forming a textbook ascending triangle, with resistance around $15.50–$16. This formation often implies an upside breakout as the price action tightens. Analysts have noted the presence of successive higher lows indicating consistent buying interest at the $16 level.
Bullish and Bearish Scenarios
The technical outlook suggests that a close above $16 with rising volume could confirm bullish momentum, potentially pushing the price to the $20–$22 range. Conversely, if INJ fails to maintain support at around $13, it may lead to a decline towards the $11–$10 level, historically noted for liquidity.
Partnership with Republic and Its Significance
Injective announced its integration with Republic, granting access to Injective-native assets for three million members across 150 countries. Republic, a FINRA-registered platform, has substantial experience in fundraising and could accelerate the development of tokenized products within this collaboration.
The current technical levels of INJ and the new partnership with Republic create favorable conditions for future growth and the expansion of access to tokenized assets in the global market.
